Does PEMBROLIZUMAB Cause Bladder cancer? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Bladder cancer have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
25
Reports of Bladder cancer with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
5
Deaths
10
Hospitalizations
How Dangerous Is Bladder cancer From PEMBROLIZUMAB?
Of the 25 reports, 5 (20.0%) resulted in death, 10 (40.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Bladder cancer Listed in the Official Label?
Yes, Bladder cancer is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Bladder cancer?
RANITIDINE (41,984)
PIOGLITAZONE (7,295)
METFORMIN\PIOGLITAZONE (278)
ADALIMUMAB (268)
ETANERCEPT (225)
METHOTREXATE (179)
INFLIXIMAB (165)
APIXABAN (159)
VALSARTAN (144)
LENALIDOMIDE (120)
Which PEMBROLIZUMAB Alternatives Have Lower Bladder cancer Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G